Report Detail
Global Prostaglandin E2 Receptor EP4 Subtype Market Insights, Forecast to 2025
- RnM2983549 |
- 19 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Prostaglandin E2 Receptor EP4 Subtype market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Prostaglandin E2 Receptor EP4 Subtype market based on company, product type, end user and key regions.
This report studies the global market size of Prostaglandin E2 Receptor EP4 Subtype in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostaglandin E2 Receptor EP4 Subtype in these regions.
This research report categorizes the global Prostaglandin E2 Receptor EP4 Subtype market by top players/brands, region, type and end user. This report also studies the global Prostaglandin E2 Receptor EP4 Subtype market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eisai Co Ltd
Eli Lilly and Co
Kaken Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
RaQualia Pharma Inc
Rottapharm Biotech Srl
Market size by Product
E-7046
ER-886046
grapiprant
KAG-308
ONO-4232
Others
Market size by End User
Breast Cancer
Allergies
Chronic Pain
Acute Pain
Lung Cancer
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Prostaglandin E2 Receptor EP4 Subtype market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Prostaglandin E2 Receptor EP4 Subtype market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Prostaglandin E2 Receptor EP4 Subtype companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Prostaglandin E2 Receptor EP4 Subtype submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Prostaglandin E2 Receptor EP4 Subtype are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prostaglandin E2 Receptor EP4 Subtype market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Prostaglandin E2 Receptor EP4 Subtype Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Product
- 1.4.2 E-7046
- 1.4.3 ER-886046
- 1.4.4 grapiprant
- 1.4.5 KAG-308
- 1.4.6 ONO-4232
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by End User
- 1.5.2 Breast Cancer
- 1.5.3 Allergies
- 1.5.4 Chronic Pain
- 1.5.5 Acute Pain
- 1.5.6 Lung Cancer
- 1.5.7 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size
- 2.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue 2014-2025
- 2.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Sales 2014-2025
- 2.2 Prostaglandin E2 Receptor EP4 Subtype Growth Rate by Regions
- 2.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales by Regions
- 2.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Prostaglandin E2 Receptor EP4 Subtype Sales by Manufacturers
- 3.1.1 Prostaglandin E2 Receptor EP4 Subtype Sales by Manufacturers
- 3.1.2 Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Manufacturers
- 3.1.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Concentration Ratio (CR5 and HHI)
- 3.2 Prostaglandin E2 Receptor EP4 Subtype Revenue by Manufacturers
- 3.2.1 Prostaglandin E2 Receptor EP4 Subtype Revenue by Manufacturers (2014-2019)
- 3.2.2 Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Manufacturers (2014-2019)
- 3.3 Prostaglandin E2 Receptor EP4 Subtype Price by Manufacturers
- 3.4 Prostaglandin E2 Receptor EP4 Subtype Manufacturing Base Distribution, Product Types
- 3.4.1 Prostaglandin E2 Receptor EP4 Subtype Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Prostaglandin E2 Receptor EP4 Subtype Product Type
- 3.4.3 Date of International Manufacturers Enter into Prostaglandin E2 Receptor EP4 Subtype Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales by Product
- 4.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Product
- 4.3 Prostaglandin E2 Receptor EP4 Subtype Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Prostaglandin E2 Receptor EP4 Subtype Breakdown Data by End User
6 North America
- 6.1 North America Prostaglandin E2 Receptor EP4 Subtype by Countries
- 6.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Sales by Countries
- 6.1.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Prostaglandin E2 Receptor EP4 Subtype by Product
- 6.3 North America Prostaglandin E2 Receptor EP4 Subtype by End User
7 Europe
- 7.1 Europe Prostaglandin E2 Receptor EP4 Subtype by Countries
- 7.1.1 Europe Prostaglandin E2 Receptor EP4 Subtype Sales by Countries
- 7.1.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Prostaglandin E2 Receptor EP4 Subtype by Product
- 7.3 Europe Prostaglandin E2 Receptor EP4 Subtype by End User
8 Asia Pacific
- 8.1 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype by Countries
- 8.1.1 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Sales by Countries
- 8.1.2 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype by Product
- 8.3 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype by End User
9 Central & South America
- 9.1 Central & South America Prostaglandin E2 Receptor EP4 Subtype by Countries
- 9.1.1 Central & South America Prostaglandin E2 Receptor EP4 Subtype Sales by Countries
- 9.1.2 Central & South America Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Prostaglandin E2 Receptor EP4 Subtype by Product
- 9.3 Central & South America Prostaglandin E2 Receptor EP4 Subtype by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype by Countries
- 10.1.1 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Sales by Countries
- 10.1.2 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype by Product
- 10.3 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype by End User
11 Company Profiles
- 11.1 Eisai Co Ltd
- 11.1.1 Eisai Co Ltd Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
- 11.1.5 Eisai Co Ltd Recent Development
- 11.2 Eli Lilly and Co
- 11.2.1 Eli Lilly and Co Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Products Offered
- 11.2.5 Eli Lilly and Co Recent Development
- 11.3 Kaken Pharmaceutical Co Ltd
- 11.3.1 Kaken Pharmaceutical Co Ltd Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
- 11.3.5 Kaken Pharmaceutical Co Ltd Recent Development
- 11.4 Ono Pharmaceutical Co Ltd
- 11.4.1 Ono Pharmaceutical Co Ltd Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
- 11.4.5 Ono Pharmaceutical Co Ltd Recent Development
- 11.5 RaQualia Pharma Inc
- 11.5.1 RaQualia Pharma Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Products Offered
- 11.5.5 RaQualia Pharma Inc Recent Development
- 11.6 Rottapharm Biotech Srl
- 11.6.1 Rottapharm Biotech Srl Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Products Offered
- 11.6.5 Rottapharm Biotech Srl Recent Development
12 Future Forecast
- 12.1 Prostaglandin E2 Receptor EP4 Subtype Market Forecast by Regions
- 12.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Regions 2019-2025
- 12.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast by Regions 2019-2025
- 12.2 Prostaglandin E2 Receptor EP4 Subtype Market Forecast by Product
- 12.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Product 2019-2025
- 12.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast by Product 2019-2025
- 12.3 Prostaglandin E2 Receptor EP4 Subtype Market Forecast by End User
- 12.4 North America Prostaglandin E2 Receptor EP4 Subtype Forecast
- 12.5 Europe Prostaglandin E2 Receptor EP4 Subtype Forecast
- 12.6 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Forecast
- 12.7 Central & South America Prostaglandin E2 Receptor EP4 Subtype Forecast
- 12.8 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Prostaglandin E2 Receptor EP4 Subtype Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Prostaglandin E2 Receptor EP4 Subtype . Industry analysis & Market Report on Prostaglandin E2 Receptor EP4 Subtype is a syndicated market report, published as Global Prostaglandin E2 Receptor EP4 Subtype Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Prostaglandin E2 Receptor EP4 Subtype market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
